FP7H2020HORIZON
Anaxomics Biotech SL
- Country
- ESSpain
- Defence projects
- 0
- Projects, all programmes
- 19
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 5,848,996
- Active
- 2009 to 2023
Projects
19 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| CarrerasLeadersCarreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers | HORIZON | 2023 | Associated partner | EUR 0 |
| halt-RONINDiscovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies | HORIZON | 2022 | Participant | EUR 373,000 |
| PROTrEINComputational Proteomics Training European Innovative Network | H2020 | 2021 | Participant | EUR 250,905 |
| proEVLifeCycleThe life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance | H2020 | 2019 | Participant | EUR 250,905 |
| HELICALHEalth data LInkage for ClinicAL benefit | H2020 | 2019 | Participant | EUR 250,905 |
| SECRETExploitation of the SECRETory pathway for cancer therapy to address European research | H2020 | 2019 | Participant | EUR 250,905 |
| COSMICCOmbatting disorders of adaptive immunity with Systems MedICine | H2020 | 2018 | Participant | EUR 247,873 |
| DRIVEDriving next generation autophagy researchers towards translation | H2020 | 2017 | Participant | EUR 247,873 |
| TREATMENTTraining European Network: Metabolic Dysfunctions associated with Pharmacological Treatment of Schizophrenia | H2020 | 2017 | Partner | EUR 0 |
| LIVERHOPESIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS | H2020 | 2017 | Participant | EUR 223,875 |
| INDOXOptimized oxidoreductases for medium and large scale industrial biotransformations | FP7 | 2013 | Participant | EUR 349,200 |
| TRIGGERKing of hearts, joints and lungs; periodontal pathogens as etiologic factor in RA, CVD and COPD and their impact on treatment strategies | FP7 | 2013 | Participant | EUR 299,660 |
| SYSMALVACIdentifying correlates of protection to accelerate vaccine trials: systems evaluation of two models of experimentally-induced immunity to malaria | FP7 | 2013 | Participant | EUR 294,534 |
| COMBIMSA novel drug discovery method based on systems biology: combination therapy and biomarkers for Multiple Sclerosis | FP7 | 2013 | Participant | EUR 299,324 |
| SYSTEMAGEEarly warning signals of ageing in human stem cells and age-related disorders | FP7 | 2013 | Participant | EUR 1,423,240 |
| VISIONProlonged inhibition of semaphorine3a pathway via a bio-degradable implant towards a better therapy for visual sensory impairments | FP7 | 2012 | Participant | EUR 466,160 |
| RAPIDRheumatoid Arthritis and Periodontal Inflammatory Disease (RAPID) | FP7 | 2012 | Participant | EUR 228,204 |
| GUMS AND JOINTSProtein citrullination as a link between periodontal diseases and rheumatoid arthritis (RA) and target for development of novel drugs to treat RA | FP7 | 2010 | Participant | EUR 160,889 |
| ANTIPATHOGNIdentification and validation of novel drug targets in Gram-negative bacteria by global search: a trans-system approach | FP7 | 2009 | Participant | EUR 231,544 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.